Orthonika
London
About Orthonika
Meniscus injury can be severely debilitating and may lead to osteoarthritis and the need for knee arthroplasty. Today’s treatment options are limited resulting in a high unmet need. As for example, partial meniscectomy does not restore full joint biomechanics and is thought to lead to knee osteoarthritis. Partial replacement is only suitable as long as the meniscal rim is intact. Allograft transplantation has severe limitations including donor availability, risk of infection and sizing.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.8M
- Funding stage: Seed
- Last round: Grant (May 2023)
- Website: orthonika.com
- Phone: [email protected]
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/orthonika-46569 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.